p97
p97 is a AAA-type ATPase that involved in mitosis-related events, such as golgi stacks fragmentation, tER formation, spindle pole body function and homotypic membrane fusion etc.
Products for p97
- Cat.No. Product Name Information
-
GC16351
CB-5083
p97 inhibitor
-
GC20117
CB-5339
CB-5339 is a second generation, potent and selective, orally bioavailable, ATP-competitive, small molecule inhibitor of valosin containing protein (VCP)/p97 [1,2].
- GC10824 DBeQ P97 ATPase inhibitor
- GC14059 ML 240 ATP-competitive inhibitor of p97 ATPase
- GC11749 ML241 p97 ATPase inhibitor
- GC13656 ML241 hydrochloride p97 ATPase inhibitor
- GC10048 MNS Inhibitor of Src/Syk tyrosine kinases
- GC60257 MSC1094308 MSC1094308 is a non-competitive and reversible VPS4B/p97 (VCP) (I/II type AAA ATPase) allosteric inhibitor, with IC50 values of 0.71 μM and 7.2 μM for VPS4B and p97, respectively. MSC1094308 inhibits the D2 ATPase activity by binding to a drugable hotspot of p97. MSC1094308 can be used in study of cancer.
- GC32874 NMS-859 NMS-859 is a potent, covalent VCP (p97) inhibitor, with IC50s of 0.37 and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.
- GC17250 NMS-873 VCP/p97 inhibitor,selective and allosteric
- GC64694 UPCDC-30245 UPCDC-30245 is an allosteric p97 inhibitor with an IC50 of approximately 27 nM. UPCDC-30245 inhibits the p97 mutant N660K similar to wild type (WT; IC50=300 nM) and shows 3-fold resistance for p97 mutant T688A. UPCDC-30245 can be used in the research of cancer.